Core Laboratories CLB Deferred Compensation Liability, Classified, Noncurrent
Deferred Compensation Liability, Classified, Noncurrent at other companies
Other financials
Where this comes from
Reported directly by Core Laboratories in its filing.
Tagged under the XBRL concept us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent.
The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Core Laboratories's deferred compensation liability, classified, noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Core Laboratories's deferred compensation liability, classified, noncurrent?
- Core Laboratories (CLB) reported deferred compensation liability, classified, noncurrent of $28.17M in Q1 2026.
- How has Core Laboratories's deferred compensation liability, classified, noncurrent changed year-over-year?
- Core Laboratories's deferred compensation liability, classified, noncurrent decreased by 3.5% year-over-year, from $29.2M to $28.17M.
- What is the long-term trend for Core Laboratories's deferred compensation liability, classified, noncurrent?
- Over 3 years (2022 to 2025), Core Laboratories's deferred compensation liability, classified, noncurrent has grown at a -2.6% compound annual growth rate (CAGR), from $31.81M to $29.38M.